Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIASCLEDINE 300 mg versus placebo in hip osteoarthritis
2004-000979-33Phase 3Completed
- Sponsor
- Laboratoire Expanscience
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hip osteoarthritis comparing PIASCLEDINE 300 mg with Placebo (2 arms). Started Jan 2006; status: completed.
02
Drugs
avocado-soybean unsaponifiables
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on 2004-000979-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000979-33.